Protease-activated receptors in the brain: Receptor expression, activation, and functions in neurodegeneration and neuroprotection

Weibo Luo, Yingfei Wang, Georg Reiser

Research output: Contribution to journalReview article

124 Citations (Scopus)

Abstract

Protease-activated receptors (PARs) are G protein-coupled receptors that regulate the cellular response to extracellular serine proteases, like thrombin, trypsin, and tryptase. The PAR family consists of four members: PAR-1, -3, and -4 as thrombin receptors and PAR-2 as the trypsin/tryptase receptor, which are abundantly expressed in the brain throughout development. Recent evidence has supported the direct involvement of PARs in brain development and function. The expression of PARs in the brain is differentially upregulated or downregulated under pathological conditions in neurodegenerative disorders, like Parkinson's disease, Alzheimer's disease, multiple sclerosis, stroke, and human immunodeficiency virus-associated dementia. Activation of PARs mediates cell death or cell survival in the brain, depending on the amplitude and the duration of agonist stimulation. Interference or potentiation of PAR activation is beneficial in animal models of neurodegenerative diseases. Therefore, PARs mediate either neurodegeneration or neuroprotection in neurodegenerative diseases and represent attractive therapeutic targets for treatment of brain injuries. Here, we review the abnormal expression of PARs in the brain under pathological conditions, the functions of PARs in neurodegenerative disorders, and the molecular mechanisms involved.

Original languageEnglish (US)
Pages (from-to)331-345
Number of pages15
JournalBrain Research Reviews
Volume56
Issue number2
DOIs
StatePublished - Dec 1 2007

Fingerprint

Proteinase-Activated Receptors
Brain
Neurodegenerative Diseases
PAR-2 Receptor
Tryptases
PAR-1 Receptor
Thrombin Receptors
Neuroprotection
G-Protein-Coupled Receptors
Thrombin
Brain Injuries
Multiple Sclerosis
Parkinson Disease
Dementia
Cell Survival
Alzheimer Disease
Cell Death
Down-Regulation
Animal Models
Stroke

Keywords

  • Central nervous system
  • Neurodegeneration
  • Neuroprotection
  • Protease-activated receptor
  • Serine protease
  • Signaling

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology

Cite this

Protease-activated receptors in the brain : Receptor expression, activation, and functions in neurodegeneration and neuroprotection. / Luo, Weibo; Wang, Yingfei; Reiser, Georg.

In: Brain Research Reviews, Vol. 56, No. 2, 01.12.2007, p. 331-345.

Research output: Contribution to journalReview article

@article{5b49e55767b44ddbb2eac7c4ff22b3a5,
title = "Protease-activated receptors in the brain: Receptor expression, activation, and functions in neurodegeneration and neuroprotection",
abstract = "Protease-activated receptors (PARs) are G protein-coupled receptors that regulate the cellular response to extracellular serine proteases, like thrombin, trypsin, and tryptase. The PAR family consists of four members: PAR-1, -3, and -4 as thrombin receptors and PAR-2 as the trypsin/tryptase receptor, which are abundantly expressed in the brain throughout development. Recent evidence has supported the direct involvement of PARs in brain development and function. The expression of PARs in the brain is differentially upregulated or downregulated under pathological conditions in neurodegenerative disorders, like Parkinson's disease, Alzheimer's disease, multiple sclerosis, stroke, and human immunodeficiency virus-associated dementia. Activation of PARs mediates cell death or cell survival in the brain, depending on the amplitude and the duration of agonist stimulation. Interference or potentiation of PAR activation is beneficial in animal models of neurodegenerative diseases. Therefore, PARs mediate either neurodegeneration or neuroprotection in neurodegenerative diseases and represent attractive therapeutic targets for treatment of brain injuries. Here, we review the abnormal expression of PARs in the brain under pathological conditions, the functions of PARs in neurodegenerative disorders, and the molecular mechanisms involved.",
keywords = "Central nervous system, Neurodegeneration, Neuroprotection, Protease-activated receptor, Serine protease, Signaling",
author = "Weibo Luo and Yingfei Wang and Georg Reiser",
year = "2007",
month = "12",
day = "1",
doi = "10.1016/j.brainresrev.2007.08.002",
language = "English (US)",
volume = "56",
pages = "331--345",
journal = "Brain Research Reviews",
issn = "0165-0173",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Protease-activated receptors in the brain

T2 - Receptor expression, activation, and functions in neurodegeneration and neuroprotection

AU - Luo, Weibo

AU - Wang, Yingfei

AU - Reiser, Georg

PY - 2007/12/1

Y1 - 2007/12/1

N2 - Protease-activated receptors (PARs) are G protein-coupled receptors that regulate the cellular response to extracellular serine proteases, like thrombin, trypsin, and tryptase. The PAR family consists of four members: PAR-1, -3, and -4 as thrombin receptors and PAR-2 as the trypsin/tryptase receptor, which are abundantly expressed in the brain throughout development. Recent evidence has supported the direct involvement of PARs in brain development and function. The expression of PARs in the brain is differentially upregulated or downregulated under pathological conditions in neurodegenerative disorders, like Parkinson's disease, Alzheimer's disease, multiple sclerosis, stroke, and human immunodeficiency virus-associated dementia. Activation of PARs mediates cell death or cell survival in the brain, depending on the amplitude and the duration of agonist stimulation. Interference or potentiation of PAR activation is beneficial in animal models of neurodegenerative diseases. Therefore, PARs mediate either neurodegeneration or neuroprotection in neurodegenerative diseases and represent attractive therapeutic targets for treatment of brain injuries. Here, we review the abnormal expression of PARs in the brain under pathological conditions, the functions of PARs in neurodegenerative disorders, and the molecular mechanisms involved.

AB - Protease-activated receptors (PARs) are G protein-coupled receptors that regulate the cellular response to extracellular serine proteases, like thrombin, trypsin, and tryptase. The PAR family consists of four members: PAR-1, -3, and -4 as thrombin receptors and PAR-2 as the trypsin/tryptase receptor, which are abundantly expressed in the brain throughout development. Recent evidence has supported the direct involvement of PARs in brain development and function. The expression of PARs in the brain is differentially upregulated or downregulated under pathological conditions in neurodegenerative disorders, like Parkinson's disease, Alzheimer's disease, multiple sclerosis, stroke, and human immunodeficiency virus-associated dementia. Activation of PARs mediates cell death or cell survival in the brain, depending on the amplitude and the duration of agonist stimulation. Interference or potentiation of PAR activation is beneficial in animal models of neurodegenerative diseases. Therefore, PARs mediate either neurodegeneration or neuroprotection in neurodegenerative diseases and represent attractive therapeutic targets for treatment of brain injuries. Here, we review the abnormal expression of PARs in the brain under pathological conditions, the functions of PARs in neurodegenerative disorders, and the molecular mechanisms involved.

KW - Central nervous system

KW - Neurodegeneration

KW - Neuroprotection

KW - Protease-activated receptor

KW - Serine protease

KW - Signaling

UR - http://www.scopus.com/inward/record.url?scp=36549089651&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36549089651&partnerID=8YFLogxK

U2 - 10.1016/j.brainresrev.2007.08.002

DO - 10.1016/j.brainresrev.2007.08.002

M3 - Review article

C2 - 17915333

AN - SCOPUS:36549089651

VL - 56

SP - 331

EP - 345

JO - Brain Research Reviews

JF - Brain Research Reviews

SN - 0165-0173

IS - 2

ER -